[1] |
Angus DC, van der Poll T. Severe sepsis and septic shock[J]. N Engl J Med, 2013, 369(9): 840-851.
|
[2] |
Yuki K, Murakami N. Sepsis pathophysiology and anesthetic consideration[J]. Cardiovasc Hematol Disord Drug Targets, 2015, 15(1): 57-69.
|
[3] |
Fleischmann C, Scherag A, Adhikari NK, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations[J]. Am J Respir Crit Care Med, 2016, 193(3): 259-272.
|
[4] |
Cohen J, Vincent JL, Adhikari NK, et al. Sepsis: a roadmap for future research[J]. Lancet Infect Dis, 2015, 15(5): 581-614.
|
[5] |
Wu H, Liu J, Li W, et al. LncRNA-HOTAIR promotes TNF-α production in cardiomyocytes of LPS-induced sepsis mice by activating NF-κB pathway[J]. Biochem Biophys Res Commun, 2016, 471(1): 240-246.
|
[6] |
Hung YL, Fang SH, Wang SC, et al. Corylin protects LPS-induced sepsis and Attenuates LPS-induced inflammatory response[J]. Sci Rep, 2017, 7(11): 46299.
|
[7] |
Thomas RC, Bath MF, Stover CM, et al. Exploring LPS-induced sepsis in rats and mice as a model to study potential protective effects of the nociceptin/orphanin FQ system[J]. Peptides, 2014, 11(61): 56-60.
|
[8] |
Su BC, Huang HN, Lin TW, et al. Epinecidin-1 protects mice from LPS-induced endotoxemia and cecal ligation and puncture-induced polymicrobial sepsis[J]. Biochim Biophys Acta Mol Basis Dis, 2017, 1863(12): 3028-3037.
|
[9] |
Chee ME, Majumder K, Mine Y. Intervention of dietary dipeptide gamma-l-glutamyl-l-valine (γ-EV) ameliorates inflammatory response in a mouse model of LPS-induced sepsis[J]. J Agric Food Chem, 2017, 65(29): 5953-5960.
|
[10] |
Fabiani IM, Rocha SL. Evaluation of sepsis treatment with enteral glutamine in rats[J]. Rev Col Bras Cir, 2017, 44(3): 231-237.
|
[11] |
Li W, Tao S, Wu Q, et al. Glutamine reduces myocardial cell apoptosis in a rat model of sepsis by promoting expression of heat shock protein 90[J]. J Surg Res, 2017, 220(12): 247-254.
|
[12] |
Yin HY, Wei JR, Zhang R, et al. Effect of glutamine on caspase-3 mRNA and protein expression in the myocardium of rats with sepsis[J]. Am J Med Sci, 2014, 348(4): 315-318.
|
[13] |
Lei J, Wei Y, Song P, et al. Cordycepin inhibits LPS-induced acute lung injury by inhibiting inflammation and oxidative stress[J]. Eur J Pharmacol, 2018, 818: 110-114.
|
[14] |
Cao ZP, Dai D, Wei PJ, et al. Effects of cordycepin on spontaneous alternation behavior and adenosine receptors expression in hippocampus[J]. Physiol Behav, 2018, 184(2): 135-142.
|
[15] |
Hwang IH, Oh SY, Jang HJ, et al. Cordycepin promotes apoptosis in renal carcinoma cells by activating the MKK7-JNK signaling pathway through inhibition of c-FLIPL expression[J]. PLoS One, 2017, 12(10): e0186489.
|
[16] |
Newton K, Dixit VM. Signaling in innate immunity and inflammation[J]. Cold Spring Harb Perspect Biol, 2012, 4(3). pii: a006049.
|
[17] |
Davies B, Cohen J. Endotoxin removal devices for the treatment of sepsis and septic shock[J]. Lancet Infect Dis, 2011, 11(1): 65-71.
|
[18] |
Deng M, Scott MJ, Loughran P, et al. Lipopolysaccharide clearance, bacterial clearance, and systemic inflammatory responses are regulated by cell type-specific functions of TLR4 during sepsis[J]. J Immunol, 2013, 190(10): 5152-5160.
|
[19] |
Bosmann M, Ward PA. The inflammatory response in sepsis[J]. Trends Immunol, 2013, 34(3): 129-136.
|
[20] |
Okur MH, Arslan S, Aydogdu B, et al. Protective effect of cordycepin on experimental testicular ischemia/reperfusion injury in rats[J]. J Invest Surg, 2018, 31(1): 1-8.
|
[21] |
Strnad P, Tacke F, Koch A, et al. Liver-guardian, modifier and target of sepsis[J]. Nat Rev Gastroenterol Hepatol, 2017, 14(1): 55-66.
|
[22] |
Premkumar M, Saxena P, Rangegowda D, et al. Coagulation failure is associated with bleeding events and clinical outcome during systemic inflammatory response and sepsis in ACLF: an observational cohort study[J]. Liver Int, 2019, 39(4): 694-704.
|
[23] |
Jenniskens M, Langouche L, Vanwijngaerden YM, et al. Cholestatic liver (dys)function during sepsis and other critical illnesses[J]. Intensive Care Med, 2016, 42(1): 16-27.
|
[24] |
Nesseler N, Launey Y, Aninat C, et al. Clinical review: the liver in sepsis[J]. Crit Care, 2012, 16(5): 235.
|
[25] |
Zhang HB, Sun LC, Zhi LD, et al. Astilbin alleviates sepsis-induced acute lung injury by inhibiting the expression of macrophage inhibitory factor in rats[J]. Arch Pharm Res, 2017, 40(10): 1176-1185.
|
[26] |
Russell JA. Management of sepsis[J]. N Engl J Med, 2006, 355(16): 1699-1713.
|
[27] |
Kuzmich NN, Sivak KV, Chubarev VN, et al. TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis[J]. Vaccines (Basel), 2017, 5(4): E34.
|